China establishes target dates for family doctor access In a newly released guideline that aims to improve healthcare, a targeted date of 2020 has been set for all people in China to have readily available access to a family doctor. This comes in light of the ever-increasing number of problems presented by the steadily aging population …
Health & Lifesciences Talking Points 27-05-2016
Call for Comments on Catalogue of Medical Devices Exempted from Clinical Trials On the 19th May the China Food and Drug Administration initiated a Public Consultation on the Draft “Catalogue of Medical Devices Exempted from Clinical Trials (second batch)”. For the full text, click here. Public Consultation on the Draft Regulatory Guidelines on Medical Device …
Health & Lifesciences Talking Points 19-03-16
China to increase organ transplantation hospitals as voluntary donation tops Asia China seeks to increase the number of hospitals habilitated to carry out organ transplant surgeries from 169 to 300 in the upcoming five years. The number of donation coordinators, whose role is to convince relatives of potential donors to help with the donation process …
Health & Lifesciences Talking Points 10-05-2016
GPs crusade over the freezing of Medicare rebates Medicare rebates are set to be a defining feature of this election cycle, with the Coalition facing stark opposition from doctors campaigning to have the national Medicare Rebates repealed. The campaign will likely affect the marginal seats, and therefore also directly affect the election. According to Morton …
Health & Lifesciences Talking Points 28-04-2016
GP’s to play bigger role in China’s Health System. 全科医生将会在中国医疗改革中发挥重要作用 The State Councils healthcare reforms for the year have been published, outlining a General Practitioner (GPs) pilot program, as well as a reduction of dependence upon drug revenue for health centres. The State Council stated that the GOP pilot program will be rolled out across …
Health & Lifesciences Talking Points 20-04-2016
Bulk billing incentives for pathologists to be scrapped on ay before election, Sussan Ley says Federal Health Minister Susan Ley, has stated that she will continue to pursue the implementation of a policy that will dispose of the current bulk billing incentives for pathologists, regardless if the date of implementation is one day prior to …
Health & Lifesciences Talking Points 11-04-2016
Online firms expanding into pharma sales China’s e-commerce is currently expanding into pharmaceuticals as the government begins to syphon prescription drug sales away from hospitals and into retail outlets. The online pharmaceutical business has expanded rapidly in recent years, up from virtually zero five years ago, to over 7 billion yuan (US$1.1 billion) in 2014. …
Health & Lifesciences Talking Points 01-04-2016
Leading Chinese healthcare company to bring improved health services to China Ciming, one of China’s leading healthcare companies, has announced plans to bring advanced medical services offered abroad, such as foreign doctors, medicines and equipment, to the home market. The chairman of Ciming Health Checkup Management Group Co Ltd, Hu Bo said that the company …
Healthcare and Lifesciences Talking Points, 25-03-2016
China’s Contribution to Global Health Security Through Pharma Partnerships Following the devastating outbreak of Ebola in 2014 many lessons were learnt in regards to how open the world was to global heath epidemics and the lack of commercial and governmental funding to tackle the spread of dangerous diseases. With the Ebola outbreak, even though the …
Healthcare and Lifesciences Talking Points, 18-03-2016
Bain Capital invests $US150 million in China healthcare Bain Capital is set to pay $US150 million to acquire a majority share in Asia Pacific Medical Group, a China focused hospital operator. The deal will be the first for the private equity firm’s new Asia fund. China’s healthcare sector has been on the rise as of …